CDK4 and cholangiocarcinoma: Dysregulation of genes encoding cell cycle components is frequent in CCA [32,33] and we have previously demonstrated that cell cycle inhibition using the CDK4/6 inhibitor Palbociclib reduces the viability of CCLP cells [16].